XML 71 R61.htm IDEA: XBRL DOCUMENT v3.22.2
OPERATING SEGMENTS (Details)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
item
segment
Jun. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Financial information of reportable segments          
Number of operating units | segment     11    
Number of reportable segments | item     3    
Net sales $ 3,580.6 $ 3,162.7 $ 6,847.3 $ 6,047.7  
Operating Income (Loss) 425.8 447.8 680.3 745.1  
Previously Reported | Valued at 2021 Management Rates          
Financial information of reportable segments          
Net sales         $ 12,733.1
Operating Income (Loss)         1,598.6
Previously Reported | Valued at 2022 Management Rates          
Financial information of reportable segments          
Net sales         12,733.1
Operating Income (Loss)         1,598.6
Global Industrial          
Financial information of reportable segments          
Net sales 1,689.9 1,544.5 3,255.6 2,975.5  
Global Institutional and Specialty          
Financial information of reportable segments          
Net sales 1,127.2 976.0 2,134.2 1,833.4  
Global Healthcare and Life Sciences          
Financial information of reportable segments          
Net sales 390.9 301.8 753.7 594.5  
Other          
Financial information of reportable segments          
Net sales 338.7 305.5 635.1 576.2  
Operating segment          
Financial information of reportable segments          
Net sales 3,616.2 3,092.6 6,871.6 5,900.9  
Operating Income (Loss) 432.2 435.0 683.9 719.1  
Operating segment | Previously Reported | Valued at 2021 Management Rates          
Financial information of reportable segments          
Net sales         12,844.8
Operating Income (Loss)         1,617.5
Operating segment | Previously Reported | Valued at 2022 Management Rates          
Financial information of reportable segments          
Net sales         12,483.6
Operating Income (Loss)         1,551.1
Operating segment | Purchase Price Adjustments | Changes in Currency Rates          
Financial information of reportable segments          
Net sales         (361.2)
Operating Income (Loss)         (66.4)
Operating segment | Global Industrial          
Financial information of reportable segments          
Net sales 1,704.1 1,502.3 3,261.1 2,887.2  
Operating Income (Loss) 227.0 251.3 416.2 461.1  
Operating segment | Global Industrial | Previously Reported | Valued at 2021 Management Rates          
Financial information of reportable segments          
Net sales         6,304.9
Operating Income (Loss)         1,031.0
Operating segment | Global Industrial | Previously Reported | Valued at 2022 Management Rates          
Financial information of reportable segments          
Net sales         6,086.8
Operating Income (Loss)         985.7
Operating segment | Global Industrial | Purchase Price Adjustments | Changes in Currency Rates          
Financial information of reportable segments          
Net sales         (218.1)
Operating Income (Loss)         (49.3)
Operating segment | Global Industrial | Purchase Price Adjustments | Segment Changes          
Financial information of reportable segments          
Operating Income (Loss)         4.0
Operating segment | Global Institutional and Specialty          
Financial information of reportable segments          
Net sales 1,135.1 963.5 2,140.2 1,807.6  
Operating Income (Loss) 152.6 137.7 263.4 199.6  
Operating segment | Global Institutional and Specialty | Previously Reported | Valued at 2021 Management Rates          
Financial information of reportable segments          
Net sales         3,978.2
Operating Income (Loss)         556.9
Operating segment | Global Institutional and Specialty | Previously Reported | Valued at 2022 Management Rates          
Financial information of reportable segments          
Net sales         3,908.8
Operating Income (Loss)         545.7
Operating segment | Global Institutional and Specialty | Purchase Price Adjustments | Changes in Currency Rates          
Financial information of reportable segments          
Net sales         (69.4)
Operating Income (Loss)         (7.4)
Operating segment | Global Institutional and Specialty | Purchase Price Adjustments | Segment Changes          
Financial information of reportable segments          
Operating Income (Loss)         (3.8)
Operating segment | Global Healthcare and Life Sciences          
Financial information of reportable segments          
Net sales 400.8 292.0 763.4 573.1  
Operating Income (Loss) 58.5 46.1 102.6 88.7  
Operating segment | Global Healthcare and Life Sciences | Previously Reported | Valued at 2021 Management Rates          
Financial information of reportable segments          
Net sales         1,195.4
Operating Income (Loss)         160.9
Operating segment | Global Healthcare and Life Sciences | Previously Reported | Valued at 2022 Management Rates          
Financial information of reportable segments          
Net sales         1,149.6
Operating Income (Loss)         152.3
Operating segment | Global Healthcare and Life Sciences | Purchase Price Adjustments | Changes in Currency Rates          
Financial information of reportable segments          
Net sales         (45.8)
Operating Income (Loss)         (7.7)
Operating segment | Global Healthcare and Life Sciences | Purchase Price Adjustments | Segment Changes          
Financial information of reportable segments          
Operating Income (Loss)         (0.9)
Operating segment | Other          
Financial information of reportable segments          
Net sales 342.3 300.3 638.3 565.7  
Operating Income (Loss) 52.0 50.8 89.2 83.1  
Operating segment | Other | Previously Reported | Valued at 2021 Management Rates          
Financial information of reportable segments          
Net sales         1,226.9
Operating Income (Loss)         187.3
Operating segment | Other | Previously Reported | Valued at 2022 Management Rates          
Financial information of reportable segments          
Net sales         1,201.0
Operating Income (Loss)         184.0
Operating segment | Other | Purchase Price Adjustments | Changes in Currency Rates          
Financial information of reportable segments          
Net sales         (25.9)
Operating Income (Loss)         (4.0)
Operating segment | Other | Purchase Price Adjustments | Segment Changes          
Financial information of reportable segments          
Operating Income (Loss)         0.7
Currency impact          
Financial information of reportable segments          
Net sales (35.6) 70.1 (24.3) 146.8  
Operating Income (Loss) (6.4) 12.8 (3.6) 26.0  
Currency impact | Previously Reported | Valued at 2021 Management Rates          
Financial information of reportable segments          
Net sales         (111.7)
Operating Income (Loss)         (18.9)
Currency impact | Previously Reported | Valued at 2022 Management Rates          
Financial information of reportable segments          
Net sales         249.5
Operating Income (Loss)         47.5
Currency impact | Purchase Price Adjustments | Changes in Currency Rates          
Financial information of reportable segments          
Net sales         361.2
Operating Income (Loss)         66.4
Corporate          
Financial information of reportable segments          
Net sales 33.9 34.9 68.7 68.1  
Operating Income (Loss) (57.9) (50.9) (187.5) (113.4)  
Corporate | Valued at 2021 Management Rates          
Financial information of reportable segments          
Net sales $ 33.9 $ 34.5 $ 68.6 $ 67.3  
Corporate | Previously Reported | Valued at 2021 Management Rates          
Financial information of reportable segments          
Net sales         139.4
Operating Income (Loss)         (318.6)
Corporate | Previously Reported | Valued at 2022 Management Rates          
Financial information of reportable segments          
Net sales         137.4
Operating Income (Loss)         (316.6)
Corporate | Purchase Price Adjustments | Changes in Currency Rates          
Financial information of reportable segments          
Net sales         (2.0)
Operating Income (Loss)         $ 2.0